Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
How plants pass defenses to offspring through a complex molecular network
A biochemist who mapped the ways in which molecular pathways interact passed away at age 96.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
David Rimoin, a medical geneticist and the founding president of the American College of Medical Genetics and Genomics, passes away at age 75.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
In rhesus macaques, an individual's drop in the social hierarchy leads to overactive immune genes and, possibly, poor health.